StockData
Xenetic Biosciences, Inc. logo

Xenetic Biosciences, Inc. (XBIO) stock

XBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3064% below fair value
$1.61+0.12 (+8.05%)

Close on Nov 17, 2026Market cap $3.77MP/E –Yield –

Xenetic Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Xenetic Biosciences's price to book ratio was 0.7× on Nov 11, 2026, against 1.0× a year earlier. Over the last 5 years it ranged from 0.3× to 1.6×, with a median of 0.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.7×−0.1
2025Dec 31, 20250.8×−0.0
2024Dec 31, 20240.9×+0.4
2023Dec 29, 20230.5×+0.2
2022Dec 30, 20220.3×−0.6
2021Dec 31, 20210.9×−0.8
2020Dec 31, 20201.6×+1.2
2019Dec 31, 20190.4×−0.9
2018Dec 31, 20181.4×−0.4
2017Dec 29, 20171.8×−4.2
2016Dec 30, 20166.0×–

More Xenetic Biosciences figures

See a number that looks wrong?